I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 522.3 ILS 2.94% Market Closed
Market Cap: 251.2m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Interest Income Expense Peer Comparison

Comparables:
TEVA
SLGL
MDWD
S
SEMG
R
REKA

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Interest Income Expense
-â‚Ş23.8m
CAGR 3-Years
N/A
CAGR 5-Years
-66%
CAGR 10-Years
-17%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Interest Income Expense
-$1B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Interest Income Expense
$1.9m
CAGR 3-Years
54%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Interest Income Expense
-$4.6m
CAGR 3-Years
-67%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
S
Seach Medical Group Ltd
TASE:SEMG
Interest Income Expense
-â‚Ş2.2m
CAGR 3-Years
N/A
CAGR 5-Years
-27%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Interest Income Expense
-â‚Ş9m
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-3%

See Also

What is InterCure Ltd's Interest Income Expense?
Interest Income Expense
-23.8m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Interest Income Expense amounts to -23.8m ILS.

What is InterCure Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-17%

Over the last year, the Interest Income Expense growth was -54%.

Back to Top